Canaccord Genuity Reiterates Buy Rating on Biodesix (BDSX) Jan 13, 2026 06:30AM
Canaccord Genuity Reiterates Buy Rating on Biodesix (BDSX) Nov 4, 2025 03:19AM
Biodesix (BDSX) PT Lowered to $20 at Canaccord Genuity Sep 19, 2025 03:34AM
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference Aug 5, 2025 06:00AM
Biodesix (BDSX) PT Lowered to $1.50 at Canaccord Genuity May 14, 2025 04:33AM


Oct 29, 2024 06:00AM Biodesix to Participate in Three Investor Conferences in November
Aug 6, 2024 06:00AM Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
Apr 5, 2024 07:17AM Biodesix (BDSX) Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
Apr 5, 2024 07:17AM Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
Nov 9, 2023 06:00AM Biodesix to Participate in Two Upcoming Investor Conferences in November
Aug 1, 2023 06:00AM Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
Aug 3, 2022 06:00AM Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference
Nov 11, 2021 06:00AM Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
Nov 1, 2021 08:08AM Biodesix (BDSX) PT Lowered to $24 at Canaccord Genuity
Aug 2, 2021 06:00AM Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference
Jan 11, 2021 07:49AM Biodesix (BDSX) PT Raised to $27 at Canaccord Genuity
Nov 23, 2020 07:50AM Canaccord Genuity Starts Biodesix (BDSX) at Buy
Oct 30, 2020 04:15PM Biodesix Announces Closing of Initial Public Offering
Oct 28, 2020 12:42PM Biodesix (BDSX) IPO Opens 25% Lower
Oct 28, 2020 05:51AM Biodesix Inc. (BDSX) Prices 4M Share IPO at $18/Sh
Oct 28, 2020 05:00AM Biodesix Announces Pricing of Initial Public Offering